title: [Polyamine and middle-molecule peptide levels in patients with chronic myeloid leukemia during treatment].
abstract: Proliferative activity of myeloblasts as well as the content of possible regulators of hemopoiesis--polyamines and medium-molecular peptides were investigated in the time course of chronic myeloid leukemia. It has been noted that their levels correlate with the leukemic process progressing, and with the response to the chemotherapy conducted.
authors.forename: V I
authors.initials: VI
authors.lastname: Shardakov
authors.forename: V T
authors.initials: VT
authors.lastname: Dem'ianova
authors.forename: V N
authors.initials: VN
authors.lastname: Pankov
authors.forename: S A
authors.initials: SA
authors.lastname: Sitnikov
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D010455:Peptides / Q000378:metabolism*; D010956:Plasmapheresis; D011073:Polyamines / Q000378:metabolism*; D011700:Putrescine / Q000378:metabolism; D013095:Spermidine / Q000378:metabolism; D013096:Spermine / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D010455:Peptides; D011073:Polyamines; D013096:Spermine; D013095:Spermidine; D011700:Putrescine
vernacular_title: Soderzhanie poliaminov i srednemolekuliarnykh peptidov u bol'nykh khronicheskim mieloleĭkozom v protsesse lecheniia.